Diclofenac Potassium

Contusions, Pain, Photophobia + 54 more

Treatment

10 FDA approvals

20 Active Studies for Diclofenac Potassium

What is Diclofenac Potassium

Diclofenac

The Generic name of this drug

Treatment Summary

Diclofenac is a type of anti-inflammatory medication used to reduce pain and inflammation caused by a variety of conditions. It works by blocking enzymes that produce hormones that cause inflammation and pain. It is often used as a first-line treatment for acute and chronic pain, and is sometimes taken in combination with another drug to prevent stomach ulcers. Diclofenac was first approved by the FDA in 1988 and is sold under the brand name Voltaren.

Voltaren

is the brand name

image of different drug pills on a surface

Diclofenac Potassium Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Voltaren

Diclofenac

1988

767

Approved as Treatment by the FDA

Diclofenac, also called Voltaren, is approved by the FDA for 10 uses including Osteoarthritis of the Knee and Pain .

Osteoarthritis of the Knee

Used to treat Osteoarthritis of the Knee in combination with Capsaicin

Pain

Helps manage Pain

Osteoarthritis

Used to treat Osteoarthritis (OA) in combination with Misoprostol

Osteoarthritis (OA)

Used to treat Osteoarthritis (OA) in combination with Misoprostol

Stomach Ulcer

Used to treat develop NSAID-induced gastric ulcers in combination with Misoprostol

Postoperative Inflammatory Response

Chronic Pain

Helps manage Pain

Osteoarthritis of the Knee

Used to treat Osteoarthritis of the Knee in combination with Capsaicin

Rheumatoid Arthritis

Cataract Surgery

Effectiveness

How Diclofenac Potassium Affects Patients

Diclofenac is used to reduce pain, inflammation, and fever. However, it can also increase the chances of developing a stomach ulcer because it reduces the amount of protective mucus in the stomach.

How Diclofenac Potassium works in the body

Diclofenac works by blocking the enzymes responsible for producing prostaglandin molecules. These molecules are responsible for pain and inflammation, so when they are blocked, the pain and inflammation is reduced. Diclofenac also reduces sensitivity to heat and other stimuli, as well as preventing white blood cells from flowing to sites of inflammation. It also reduces the activity of NF-Kappa B, a contributor to cancer, and stops tumor suppressor proteins from leaving the cell. Finally, it stops the activity of neurons in the hypothalamus that create a fever. All of these effects work together to reduce pain and inflammation caused

When to interrupt dosage

The suggested measure of Diclofenac Potassium is contingent upon the determined circumstance, such as Joint Pain, Postoperative Inflammatory Response and Osteoarthritis (OA). The volume of dosage can be found in the table presented below, depending on the mode of administration (e.g. Cream; Kit; Solution or Kit; Oil; Solution / drops).

Condition

Dosage

Administration

Cataract Surgery

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Arthritis, Gouty

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Blunt Trauma

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Sprains and Strains

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Pharyngitis

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Photophobia

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Osteoarthritis of the Knee

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Muscle Pain

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Inflammation

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Chronic Pain

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Pericarditis

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Postoperative Pain

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Pain

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Fever

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Acute Coryza

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Postoperative

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Arthritis, Gouty

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Inflammation

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

corneal refractive surgery

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Rheumatoid Arthritis

100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg

, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution, Powder, for solution - Oral, Solution / drops, Solution / drops - Ophthalmic, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Topical, Gel, Gel - Topical, Patch, Patch - Topical, Liquid - Ophthalmic, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Solution - Topical, Kit, Aerosol, metered, Aerosol, metered - Topical, Tablet, sugar coated, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Kit - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder - Oral, Transdermal, Solution / drops - Transdermal, Oral; Topical, Kit - Oral; Topical, Tablet, coated - Oral, Drug delivery system - Topical, Tablet, coated, Drug delivery system, Sublingual

Warnings

Diclofenac Potassium Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Heart failure

Do Not Combine

Crohn's Disease

Do Not Combine

recent history of anal bleeding

Do Not Combine

Hemorrhagic Disorders

Do Not Combine

Gastritis

Do Not Combine

inflammatory lesions of the Rectum

Do Not Combine

active Gastrointestinal Bleeding

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

active Gastrointestinal Perforation

Do Not Combine

Duodenal Ulcer

Do Not Combine

Coronary Artery Bypass Grafting

Do Not Combine

Severe Hepatic Impairment

Do Not Combine

Ulcerative Colitis

Do Not Combine

Liver Diseases

Do Not Combine

Stroke

Do Not Combine

Third trimester of pregnancy

Do Not Combine

Hematochezia

Do Not Combine

Kidney Failure

Do Not Combine

Kidney Failure

Do Not Combine

Anus

Do Not Combine

Ulcer

Do Not Combine

damaged skin

Do Not Combine

Gastric ulcer

Do Not Combine

Peptic Ulcer

Do Not Combine

Hyperkalemia

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Diclofenac may interact with Pulse Frequency

There are 20 known major drug interactions with Diclofenac Potassium.

Common Diclofenac Potassium Drug Interactions

Drug Name

Risk Level

Description

Brigatinib

Major

The metabolism of Brigatinib can be decreased when combined with Diclofenac.

Cabazitaxel

Major

The metabolism of Cabazitaxel can be decreased when combined with Diclofenac.

Cyclophosphamide

Major

The metabolism of Cyclophosphamide can be decreased when combined with Diclofenac.

Enasidenib

Major

The metabolism of Enasidenib can be decreased when combined with Diclofenac.

Erlotinib

Major

The metabolism of Erlotinib can be decreased when combined with Diclofenac.

Diclofenac Potassium Toxicity & Overdose Risk

Overdosing on Voltaren can lead to symptoms such as fatigue, nausea, vomiting, upper abdominal pain, and bleeding from the digestive tract. In rare cases, patients may experience high blood pressure, kidney damage or failure, hypoventilation, or coma. Treatments for Voltaren overdose include inducing vomiting and activated charcoal, as long as the overdose occurred within the last 4 hours.

image of a doctor in a lab doing drug, clinical research

Diclofenac Potassium Novel Uses: Which Conditions Have a Clinical Trial Featuring Diclofenac Potassium?

Currently, 491 active clinical trials are assessing the capacity of Diclofenac Potassium to mitigate Inflammation, enhance Argon Laser Trabeculoplasty and assuage Osteoarthritis of the Knee.

Condition

Clinical Trials

Trial Phases

Osteoarthritis of the Knee

85 Actively Recruiting

Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1

Inflammation

61 Actively Recruiting

Not Applicable, Phase 2, Early Phase 1, Phase 3, Phase 1

Chronic Pain

128 Actively Recruiting

Not Applicable, Phase 2, Phase 4, Phase 3, Early Phase 1, Phase 1

Rheumatoid Arthritis

63 Actively Recruiting

Not Applicable, Phase 3, Phase 1, Phase 2, Phase 4

Postoperative Pain

21 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Phase 1, Early Phase 1, Phase 3

Dysmenorrhea

0 Actively Recruiting

Muscle Pain

2 Actively Recruiting

Phase 4, Phase 2

Conjunctivitis

0 Actively Recruiting

Musculoskeletal System

1 Actively Recruiting

Not Applicable

corneal refractive surgery

0 Actively Recruiting

Postoperative Inflammatory Response

0 Actively Recruiting

Photophobia

5 Actively Recruiting

Not Applicable

Pain

2 Actively Recruiting

Not Applicable

Stomach Ulcer

0 Actively Recruiting

Rheumatism

0 Actively Recruiting

Juvenile arthritis

7 Actively Recruiting

Phase 2, Not Applicable, Phase 3

radial keratotomy

0 Actively Recruiting

Joints

0 Actively Recruiting

Pericarditis

3 Actively Recruiting

Phase 2, Phase 3

Acute Coryza

0 Actively Recruiting

Diclofenac Potassium Reviews: What are patients saying about Diclofenac Potassium?

5

Patient Review

3/19/2014

Diclofenac Potassium for Rheumatic Disease causing Pain & Stiffness in Backbone

I was able to get back to my normal routine within just a few days of starting this medication. Not only that, but it didn't bother my stomach like other medications have in the past.

5

Patient Review

7/17/2014

Diclofenac Potassium for Pain

This medicine was really effective in treating my lower back pain. I would have continued to take it if it weren't for the fact that it's an NSAID, and I can't take those anymore because of stomach problems.

5

Patient Review

5/27/2014

Diclofenac Potassium for Pain

This medication was a godsend after I broke two ribs. It allowed me to function normally while it was working, and the pain was unbearable when it began to wear off.

5

Patient Review

12/25/2015

Diclofenac Potassium for Gout

I was experiencing pain in my left heel and took ibuprofen 400mg and allopurinol 100mg for more than two weeks without any relief. I started taking diclofenac potassium oral 100mg and parastaimal 500mg daily, and within two days the pain was gone.

5

Patient Review

9/9/2015

Diclofenac Potassium for Pain

This medication was a godsend for my chronic pain. I felt great within a few days and was able to move around without stiffness or pain. However, now that I'm out of my prescription, the pain has come back full force and I am miserable once again.

5

Patient Review

8/29/2015

Diclofenac Potassium for Inflammation of the Sac Surrounding the Joint - Bursitis

The pain relief I experienced from this medication was nothing short of miraculous.

5

Patient Review

5/24/2021

Diclofenac Potassium for Migraine Headache

This medication is a great rescue for migraines. It takes away about 75% of the pain, which makes it much easier to get through the day. I also haven't had any problems with taking it on an empty stomach.

5

Patient Review

1/12/2016

Diclofenac Potassium for Rheumatoid Arthritis

I'm so glad I found this drug! It's been a huge help. However, I still need to take my norco.

5

Patient Review

9/19/2016

Diclofenac Potassium for Severe Lower Back Pain from Kidney Stones

This provided immediate relief, which was great.

5

Patient Review

5/26/2019

Diclofenac Potassium for Rheumatoid Arthritis

I really appreciate this medication. It's helped me a lot.

5

Patient Review

7/4/2014

Diclofenac Potassium for Painful Periods

This medication was very effective in managing my pain during menstruation.

4.3

Patient Review

3/31/2014

Diclofenac Potassium for Inflammation of the Tendon

This treatment helped with my muscle pain.

3.3

Patient Review

2/3/2014

Diclofenac Potassium for Inflammation of the Tendon

The IT Band is a common source of pain for many people.

3

Patient Review

9/10/2017

Diclofenac Potassium for Migraine Headache

It's really tough on my stomach, and the cost is outrageous.

2.7

Patient Review

7/11/2014

Diclofenac Potassium for Inflammation of the Sac Surrounding the Joint - Bursitis

I've gone from being really cold (shivering, cold hands and feet) to being excessively hot over the entire portion of my body. Its fore an inflamed tail bone which turned red and feels like a bruise someone his constantly touching.

2

Patient Review

8/15/2014

Diclofenac Potassium for Rheumatoid Arthritis

I was hospitalized after taking just five pills of this medication. I couldn't respond to the doctor's questions. He said that this medicine caused me a lot of harm and pain. I'm still suffering and now have to use a walker, which is something new for me.

2

Patient Review

1/4/2015

Diclofenac Potassium for Joint Damage causing Pain and Loss of Function

I took this medication for approximately six weeks to treat inflammation in my shoulder joints. Unfortunately, the side effects were really terrible - I was constantly moody and got my period all the time. I would not recommend this medication for women of child-bearing age. My doctor didn't mention any of these potential side effects, so I had to figure it out on my own!

1.7

Patient Review

6/30/2016

Diclofenac Potassium for Pain

I have fibro, RA, and migraines. They took my old medication away and replaced it with this one. I feel like I'm constantly hungover and all I want to do is sleep. When I called my doctor about it, they said it wasn't the medication. Hello? If it's not the medication, then what is it? Ginger tea isn't cutting it.

1.7

Patient Review

9/13/2017

Diclofenac Potassium for Pain

I was given this medication for lower back pain, but I am now experiencing stomach pain. This is not an ideal situation, so I will have to speak with my doctor about finding a different treatment option.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about diclofenac potassium

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is diclofenac a strong painkiller?

"Diclofenac is stronger than ibuprofen and should be taken every six to eight hours. Ibuprofen usually needs to be taken in high doses to relieve pain associated with arthritis."

Answered by AI

What is diclofenac potassium used for?

"This medication is known as a nonsteroidal anti-inflammatory drug (NSAID).

This medication is used to relieve various kinds of pain and swelling, including muscle aches, backaches, dental pain, menstrual cramps, and sports injuries. It also helps reduce pain, swelling, and stiffness caused by arthritis."

Answered by AI

What are the dangers of taking diclofenac?

"NSAIDs such as diclofenac can cause painful ulcers, bleeding, or holes in the stomach or intestine. These problems can develop at any time during treatment and sometimes without any warning symptoms. In rare cases, they can even be fatal."

Answered by AI

Is diclofenac potassium a painkiller?

"If you need to take an NSAID for a long period of time, your doctor or pharmacist may recommend ibuprofen or naproxen instead of diclofenac. This is because diclofenac is more likely to cause heart problems."

Answered by AI

Clinical Trials for Diclofenac Potassium

Image of Northwell health physician partners in Bay Shore, United States.

Lidocaine Injection vs Saline for Pain Management

18+
Female
Bay Shore, NY

We are doing this study to find the best way to manage pain during a procedure called urethral bulking. This procedure treats urine leakage that happens with coughing, laughing, sneezing, or physical activity. It works by injecting a gel-like substance around the urethra (the tube that urine comes out of) to help it stay closed when it should. We use a numbing gel (called lidocaine jelly) inside the urethra to help with pain during the procedure. In this study, we will also be administering lidocaine (numbing medication) injected around the urethra or a saline placebo (medical grade saltwater) injection, which has no numbing effect. A placebo is something that looks like a real treatment but doesn't have any medical effect. Both the lidocaine and the saline would be injected around the urethra using a small needle, and we'll compare how well they work at reducing pain.

Phase 4
Recruiting

Northwell health physician partners (+2 Sites)

Image of Endeavor Health/NorthShore in Skokie, United States.

Tranexamic Acid for Anterior Cruciate Ligament Injury

14 - 25
All Sexes
Skokie, IL

The goal of this clinical trial is to learn whether taking oral tranexamic acid (TXA) for one week after anterior cruciate ligament (ACL) reconstruction improves recovery in adolescents and young adults aged 14 to 25 years. All participants receive standard intravenous TXA during surgery. The main questions it aims to answer are: * Does oral TXA lower knee pain at 2 weeks after surgery? * Does oral TXA reduce the amount of opioid pain medicine used in the first 2 weeks? * Does oral TXA improve knee range of motion at 2 weeks? Researchers will compare oral TXA to a placebo (a look-alike capsule with no active drug) to see if oral TXA improves pain, opioid use, motion, strength, knee function, and return to sport. Participants will: * Take 3 capsules (oral TXA or placebo) once a day for the first 8 days after surgery (day of surgery through day 7) * Keep a home diary for 2 weeks recording pain scores, opioid pills taken and any side effects * Return for study visits at 2 weeks, 6 weeks, 12 weeks, 6 months, 9 months and 1 year for pain, motion, strength and function testing * Complete a survey at 2 years

Phase 3
Waitlist Available

Endeavor Health/NorthShore (+5 Sites)

Have you considered Diclofenac Potassium clinical trials?

We made a collection of clinical trials featuring Diclofenac Potassium, we think they might fit your search criteria.
Go to Trials
Image of Texas Tech University Health Sciences Center/ University Medical Center Lubbock in Lubbock, United States.

PSP Monitoring for Sepsis in Burns

18 - 89
All Sexes
Lubbock, TX

The goal of this clinical trial is to learn if using pancreatic stone protein (PSP) test results helps doctors find and treat sepsis earlier in adults with serious burn injuries. The study will also look at whether using PSP is safe and practical in the burn intensive care unit. The main questions it aims to answer are: * Does seeing PSP test results help doctors start the right antibiotics sooner? * Does using PSP reduce unnecessary antibiotic use? * Does using PSP improve recovery and other health outcomes? Researchers will compare two groups of patients. One group will receive standard care, and their PSP test results will be hidden from their care team. The other group will receive standard care, but their care team will be able to see the PSP test results and use them to help make treatment decisions. Participants will: * Be randomly assigned to one of the two study groups. * Have a small blood sample taken within 24 hours after being admitted to the burn ICU and then once each weekday while they are in the ICU. * Receive the usual care for burn injuries and sepsis throughout the study.

Waitlist Available
Has No Placebo

Texas Tech University Health Sciences Center/ University Medical Center Lubbock

Brian Schneider, MD

Abionic SA

Image of Northwestern Medicine Rheumatology in Chicago, United States.

Patient-Reported Outcomes Dashboard for Inflammatory Arthritis

18+
All Sexes
Chicago, IL

The goal of this clinical trial is to learn whether showing patient-reported symptoms and personal treatment goals to rheumatology clinicians on a dashboard in the electronic health record improves shared decision-making for adults with rheumatoid arthritis or psoriatic arthritis. The main questions it aims to answer are: * Do patients whose clinicians use the dashboard report more shared decision-making during their rheumatology visits than patients who receive usual care? * Do patients in the dashboard group report greater progress toward their personal goals and more confidence in managing their symptoms after 6 months? Researchers will compare the dashboard group to a usual care group to see if the dashboard improves shared decision-making, goal attainment, and self-efficacy. Participants will: * Complete a routine symptom questionnaire before their rheumatology visits, as all clinic patients do * Choose personal treatment goals and rate their progress toward those goals 6 months later * Complete short surveys before and after two rheumatology visits about 6 months apart Participants in the dashboard group will also complete questionnaires in the patient portal about pain, fatigue, physical function, sleep, and morning stiffness before each visit. Their answers and goals will be shown to their clinician on a dashboard to guide the conversation during the visit.

Waitlist Available
Has No Placebo

Northwestern Medicine Rheumatology

Image of Hospital for Special Surgery in New York, United States.

Suzetrigine for Pain Management in Total Knee Replacement

18 - 80
All Sexes
New York, NY

Total knee replacements are among the most common and painful orthopedic procedures performed worldwide, often requiring intensive analgesia to support early ambulation and recovery. Despite widespread use of multimodal regimens, many patients still rely on opioids, which can cause sedation, nausea, constipation, and long-term dependency. Evaluating suzetrigine in this high-need population may improve recovery trajectories, reduce opioid consumption, and support enhanced recovery protocols. Given the growing surgical volume and the emphasis on opioid-sparing strategies, rigorous investigation of suzetrigine's efficacy in total knee replacement is of high clinical value. In this confirmatory (phase III) trial, patients undergoing primary total knee replacement will be randomized to receive either suzetrigine or placebo for 2 weeks (14 days), with the loading dose administered prior to surgery. The primary outcome is cumulative 48-hour opioid consumption in oral morphine equivalents starting from entry into the post-anesthesia care unit (PACU).

Phase 3
Recruiting

Hospital for Special Surgery

Meghan Kirskey, MD

Image of Nicholas Institute of Sports Medicine & Athletic Trauma (NISMAT) in New York, United States.

Fruit Juice for Inflammation

18 - 65
All Sexes
New York, NY

Dietary patterns and physical inactivity common in Western societies have been associated with chronic low-grade inflammation and an increased risk of non-communicable health conditions. Fruits and vegetables contain polyphenols and other bioactive compounds that may have antioxidant and anti-inflammatory properties and may influence inflammatory biomarkers. This study will evaluate the effects of increased consumption of a fruit juice on inflammatory biomarkers and exercise capacity in adults with mildly elevated inflammation. Approximately 40 participants will be randomly assigned to consume one of two fruit juice interventions daily for approximately 2 weeks. Changes in C-reactive protein (CRP) and exercise capacity, assessed using a 6-minute walk test, will be evaluated before and after the intervention and compared between the two groups.

Recruiting
Has No Placebo

Nicholas Institute of Sports Medicine & Athletic Trauma (NISMAT)

Christopher Tanayan, MD

Have you considered Diclofenac Potassium clinical trials?

We made a collection of clinical trials featuring Diclofenac Potassium, we think they might fit your search criteria.
Go to Trials
Image of University of Alabama at Birmingham in Birmingham, United States.

Cancer Pain 101 for Cancer Pain

18+
All Sexes
Birmingham, AL

This is a Stage 1 study of a behavioral intervention, which means that a new intervention is being pilot tested to understand whether it is acceptable and feasible for people with advanced cancer to use. The purpose of this study is to evaluate whether a series of 3 10-minute videos may help improve prescription opioid pain management and opioid stigma for people living with advanced cancer. Approximately 45 participants will take part in this study at the University of Alabama at Birmingham. People who choose to participate in this study will complete a series of baseline questionnaires, and then will be randomized to one of two groups: 1) the group that gets the video intervention, or 2) the group that gets a written handout with information about cancer pain. About 4 weeks later, all participants will also be asked to fill out another series of questionnaires.

Waitlist Available
Has No Placebo

University of Alabama at Birmingham

Hailey W Bulls, PhD

Image of M Health Fairview Clinic - Oxboro in Minneapolis, United States.

TENS and Vibration for Procedural Pain

18+
All Sexes
Minneapolis, MN

The E-MOHS Trial is a randomized controlled trial evaluating whether active vibration plus transcutaneous electrical nerve stimulation reduces pain during local anesthetic infiltration in adults undergoing Mohs micrographic surgery or dermatologic excision. Participants will be randomized to active vibration:TENS or sham TENS during the first local anesthetic administration. The primary outcome is patient-reported infiltration pain during active local anesthetic infiltration, measured using the 11-point Numeric Rating Scale. Secondary outcomes include infiltration pain measured using a Visual Analog Scale, perioperative anxiety, participant satisfaction, willingness to reuse the device, operator-rated ease of use and sterile-field compatibility, blinding integrity, and adverse events.

Waitlist Available
Background Therapy Allowed

M Health Fairview Clinic - Oxboro (+3 Sites)

Ian Maher, MD

Image of UPMC Children's Community Pediatrics in Pittsburgh, United States.

Enhanced Telemedicine for Acute Respiratory Tract Infections

6 months - 24 months
All Sexes
Pittsburgh, PA

Young children often receive antibiotics for pediatric acute respiratory tract infections (ARTIs) - common childhood diagnoses like ear infections, strep throat, sinusitis, and colds - but many of these antibiotics are prescribed unnecessarily for viral infections, where antibiotics will not help. Helping families and pediatricians to evaluate children with ARTIs through primary care telemedicine visits using at-home tele-otoscopes vs. at-home eBooks could help reduce unnecessary antibiotic exposure in children. In this clinical trial, we will assess the impact of at-home tele-otoscope vs. eBook enabled primary care telemedicine on antibiotic use, healthcare utilization, and healthcare costs for young children.

Waitlist Available
New This Month

UPMC Children's Community Pediatrics (+1 Sites)

Kristin Ray, MD, MS

Have you considered Diclofenac Potassium clinical trials?

We made a collection of clinical trials featuring Diclofenac Potassium, we think they might fit your search criteria.
Go to Trials